CELG) — Celgene Corporation (NASDAQ

Lloyd Doyle
April 16, 2018

Stephens Investment Group Ltd Liability Company holds 338,899 shares or 0.13% of its portfolio. The institutional investor held 4.54 million shares of the consumer services company at the end of 2017Q4, valued at $870.62 million, down from 5.04 million at the end of the previous reported quarter. Bristol John W & Company Inc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $67.25B market cap company. The stock increased 0.32% or $0.35 during the last trading session, reaching $110.62. About 2.17 million shares traded. Iconix Brand Group, Inc. General Electric Company (NYSE:GE) has declined 54.35% since April 16, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Northstar Asset Management Llc decreased its stake in Celgene Corporation (CELG) by 43.8% based on its latest 2017Q4 regulatory filing with the SEC. Oarsman Capital Inc sold 38,392 shares as the company's stock declined 13.12% with the market. The institutional investor held 26,054 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.72M, down from 29,001 at the end of the previous reported quarter. Cypress Capital Management Llc Wy who had been investing in Whiting Pete Corp New for a number of months, seems to be bullish on the $3.52B market cap company. CELG underperformed the S&P500 by 42.83%.

Investors sentiment decreased to 1.42 in 2017 Q4.

Since December 11, 2017, it had 0 insider purchases, and 1 insider sale for $51,700 activity. It increased, as 34 investors sold SRE shares while 165 reduced holdings. The correct version of this article can be viewed at https://stocknewstimes.com/2018/04/16/two-sigma-investments-lp-raises-stake-in-celgene-celg.html. Menora Mivtachim Limited holds 1.2% or 297,900 shares in its portfolio. The biopharmaceutical company reported $1.87 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.78 by $0.09. Comerica Securities Inc invested 0.25% in Celgene Corporation (NASDAQ:CELG). S R Schill And Assoc invested in 2,946 shares. The New York-based Alliancebernstein LP has invested 0.1% in Netflix, Inc. (NASDAQ:ICON) for 350,000 shares. Jag Capital Mgmt Limited Company reported 22,728 shares. Creative Planning has invested 0.01% of its portfolio in Leggett & Platt, Incorporated (NYSE:LEG). The company's stock declined 19.30% with the market as Edinburgh Partners Ltd bought 45,801 shares. Us Bancorp De holds 0% or 31,653 shares. Grp Inc One Trading Lp accumulated 0.02% or 129,681 shares. Alps Advsrs accumulated 5,177 shares or 0% of the stock. 34 were reported by Sei Invests Communication.

Total analysts of 28 have positions in Celgene (NASDAQ:CELG) as follows: 15 rated it a "Buy", 1 with "Sell" and 12 with "Hold". Therefore 56% are positive. Whiting Petroleum Corporation had 152 analyst reports since July 21, 2015 according to SRatingsIntel. (NASDAQ:ICON) earned "Neutral" rating by Guggenheim on Friday, September 30. Vetr raised Celgene from a "buy" rating to a "strong-buy" rating and set a $116.84 price target on the stock in a research report on Thursday, January 25th. The firm earned "Buy" rating on Thursday, September 14 by Jefferies. The stock has "Equal-Weight" rating by Barclays Capital on Wednesday, February 7. JMP Securities maintained the stock with "Mkt Outperform" rating in Friday, July 24 report. The rating was downgraded by Nomura to " on Friday, August 7. BMO Capital Markets reiterated a "buy" rating and issued a $147.00 target price on shares of Celgene in a research note on Friday, December 22nd.


Since October 26, 2017, it had 1 insider buy, and 3 insider sales for $228,453 activity. Janus Henderson Group PLC now owns 9,410,233 shares of the biopharmaceutical company's stock worth $1,372,196,000 after purchasing an additional 1,001,272 shares during the period. $1.77M worth of Celgene Corporation (NASDAQ:CELG) was sold by KAPLAN GILLA on Thursday, February 15. Netflix, Inc. (NASDAQ:NFLX) has risen 108.73% since April 16, 2017 and is uptrending. CELG's profit will be $1.34B for 12.56 P/E if the $1.78 EPS becomes a reality. Finally, Clearbridge Investments LLC raised its position in shares of Celgene by 17.0% during the fourth quarter. The firm has a market cap of $67,500.23, a price-to-earnings ratio of 13.07, a P/E/G ratio of 0.60 and a beta of 1.49. It dived, as 156 investors sold Celgene Corporation shares while 478 reduced holdings. 118 funds took stakes and 411 increased stakes.

ValuEngine downgraded shares of Celgene (NASDAQ:CELG) from a hold rating to a sell rating in a research report released on Thursday morning. National Bank & Trust stated it has 40,081 shares or 0.06% of all its holdings. Following the completion of the purchase, the insider now owns 178,904 shares of the company's stock, valued at approximately $16,441,277.60. Maple Management holds 0.17% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 6,344 shares. The Connecticut-based Kamunting Street Mngmt Limited Partnership has invested 0.82% in Celgene Corporation (NASDAQ:CELG). During the same period last year, the firm posted $1.61 earnings per share. research analysts anticipate that Celgene will post 7.66 earnings per share for the current fiscal year. Putnam Fl Mngmt invested in 121,424 shares. Granite Inv Prtnrs Ltd Limited Liability Company holds 0.04% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 5,421 shares. Invsts holds 0.01% or 635,000 shares. Nomura invested in 97,492 shares. First Midwest Comml Bank Tru Division reported 39,104 shares. Sweden-based Rhenman Prtn Asset Ab has invested 2.28% in Celgene Corporation (NASDAQ:CELG).

Capital Investment Services Of America Inc, which manages about $630.15 million US Long portfolio, decreased its stake in Polaris Industries Inc (NYSE:PII) by 3,775 shares to 76,975 shares, valued at $9.54M in 2017Q4, according to the filing.

Among 8 analysts covering Medley Capital Corp (NYSE:MCC), 2 have Buy rating, 0 Sell and 6 Hold. Therefore 25% are positive. (NYSE:HIW) on Tuesday, October 3 with "Buy" rating. The company now has a consensus rating of "Buy" and an average target price of $139.50. Finally, Cowen and Company reaffirmed an "outperform" rating and issued a $150.00 target price on shares of Celgene in a research note on Wednesday. Ark Investment Management LLC now owns 1,599 shares of the biopharmaceutical company's stock worth $208,000 after buying an additional 704 shares in the last quarter. In Friday, October 20 report Stifel Nicolaus maintained the stock with "Buy" rating. Wells Fargo maintained the shares of SRE in report on Wednesday, January 3 with "Buy" rating.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER